Citi raised the firm’s price target on GE HealthCare (GEHC) to $110 from $103 and keeps a Buy rating on the shares. Operating margins expanded ...
Sees FY25 organic revenue growth of 2%-3% year-over-year, which reflects continued demand for products and services as well as a measured view ...
GE HealthCare Q4 earnings beat estimates with strong U.S. demand. 2025 outlook includes 2%-3% revenue growth and EPS guidance of $4.61-$4.75.
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) in Q4 CY2024, with sales up 2.2% year on year to $5.32 ...
GE HealthCare Technologies delivered solid fourth-quarter earnings, but domestic and international revenue growth remained ...
GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President an ...